Dictionary of Pharmaceutical Medicine

This dictionary defines various terms typically used in pharmaceutical medicine. A new, 4th edition includes adaptations of the text to the steadily increasing regulatory requirements, particularly in the area of genetics/gene therapy, product quality (e.g., protection against falsified medicines) a...

Full description

Main Author: Nahler, Gerhard. (Author, http://id.loc.gov/vocabulary/relators/aut)
Corporate Author: SpringerLink (Online service)
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2017.
Edition:4th ed. 2017.
Subjects:
Online Access:https://doi.org/10.1007/978-3-319-50669-2
LEADER 02594nam a22004695i 4500
001 978-3-319-50669-2
003 DE-He213
005 20210619000926.0
007 cr nn 008mamaa
008 170317s2017 gw | s |||| 0|eng d
020 |a 9783319506692  |9 978-3-319-50669-2 
024 7 |a 10.1007/978-3-319-50669-2  |2 doi 
050 4 |a RS380 
050 4 |a RS190-210 
072 7 |a TDCW  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a TDC  |2 thema 
082 0 4 |a 615.19  |2 23 
100 1 |a Nahler, Gerhard.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Dictionary of Pharmaceutical Medicine  |h [electronic resource] /  |c by Gerhard Nahler. 
250 |a 4th ed. 2017. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2017. 
300 |a X, 396 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
505 0 |a Dictionary of pharmaceutical medicine -- Abbreviations/acronyms -- Selected bibliography -- Useful websites. 
520 |a This dictionary defines various terms typically used in pharmaceutical medicine. A new, 4th edition includes adaptations of the text to the steadily increasing regulatory requirements, particularly in the area of genetics/gene therapy, product quality (e.g., protection against falsified medicines) and of product safety (pharmacovigilance). Further evolving areas that are covered by the 4th edition are typical “grey zones” (health effects often borderline to medicinal products) such as cosmetics and dietary supplements where misleading information is prohibited on one hand but where any health claims need formal authorisation on the other. These but also other areas are reviewed and presented in an updated and – if justified – in an enlarged form. 
650 0 |a Pharmaceutical technology. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmaceutical Sciences/Technology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/B21010 
650 2 4 |a Pharmacy.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/F00008 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319506685 
776 0 8 |i Printed edition:  |z 9783319506708 
856 4 0 |u https://doi.org/10.1007/978-3-319-50669-2 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708)